Global life sciences consultancy to present original research whitepaper on importance of speedy MDR compliance at Medica 2017
Maetrics, the global consultancy firm that provides regulatory, quality, and compliance solutions to the life sciences sector, today announces its attendance at next months Medica trade fair in Düsseldorf (13-16 November 2017).
The company will exhibit on Stand F18-5, Hall 16 and will have senior executives available to share their experience and expertise in regulatory affairs in the medical devices sector. To coincide with the event, Maetrics will also launch a new research whitepaper on the European Medical Device Regulation (MDR), which officially came into effect in May this year and represents the single largest change to medical device regulations in Europe since CE Marking was introduced in 1993.
Specifically, the original research will quantify in clear financial terms the potential market advantage for medtech firms moving quickly to become compliant with the MDR, rather than waiting until the 2020 deadline.
Peter Rose, Managing Director for Europe at Maetrics, said: “We are delighted to exhibit at this years Medica and look forward to presenting our significant knowledge of the medical devices regulatory landscape. There are significant changes taking place that widely affect the industry – including the MDR in Europe, the new international Medical Device Single Audit Program (MDSAP) and ISO 13485:2016.
“Based on our current experience of helping medical device companies navigate these important regulatory changes and meet their obligations, we are ideally positioned to give insight into the practical implications of each regulation and the tactics being employed to achieve seamless compliance.”
Maetrics works with medical device, diagnostic, pharmaceutical and biotechnology companies to help them meet quality, compliance, and regulatory requirements while remaining competitive and profitable. With offices throughout Europe and North America, Maetrics can assist with local, regional, or global compliance needs.
--- end ---
Notes to Editors
Peter Rose – biography
Mr. Rose has worked in the medical device industry for over 24 years, bringing a wealth of experience and knowledge in quality systems and regulatory affairs to Maetrics clients. He is a lead auditor and a qualified microbiologist, and has been recognized for his extensive experience with sterilization. In addition to his Maetrics responsibilities, Mr. Rose is also a Director of Medilink East Midlands and has been a guest lecturer at the University of Nottingham, Nottingham Trent University and the University of Sheffield. He is a member of the Technical Policy Group of the ABHI and sits on the MHRA Medical Device Industry Liaison Group. He is a contributor to a number of industry journals and is sought out regularly to speak on industry topics. Mr. Rose is a graduate of the University of Sheffield -BSc (Hons) Degree in Microbiology.
Founded in 1984, Maetrics is a global life sciences consulting firm focused exclusively on regulatory, quality, and compliance solutions for Medical Device, Diagnostic, Pharmaceutical and Biotechnology companies. With offices throughout Europe and North America, Maetrics can assist with local, regional, or global compliance needs.
Exhibitor Data Sheet